Ear length in trisomy 21 fetuses at 11-14 weeks of gestation

C Sacchini1, A El-Sheikhah, S Cicero

  • 1Harris Birthright Research Centre for Fetal Medicine, King's College Hospital Medical School, London, UK.

Insights

Fetal ear length measurement at 11-14 weeks gestation shows reduced length in trisomy 21 fetuses. However, this difference is too small to be a reliable screening tool for chromosomal defects.

Area of Science:

  • Prenatal diagnosis
  • Fetal medicine
  • Genetics

Background:

  • Chromosomal abnormalities, such as trisomy 21, are significant concerns in early pregnancy.
  • Accurate screening methods are crucial for timely intervention and management.

Purpose of the Study:

  • To evaluate the diagnostic value of fetal ear length measurement in screening for chromosomal defects during the first trimester.
  • To assess the correlation between fetal ear length and crown-rump length in normal and trisomy 21 fetuses.

Main Methods:

  • Fetal ear length was measured in 450 fetuses between 11-14 weeks gestation prior to chorionic villus sampling.
  • Karyotyping was performed to determine fetal chromosomal status.
  • Ear length was analyzed in relation to crown-rump length and compared between chromosomally normal and abnormal fetuses.

Main Results:

  • Fetal ear length significantly increased with crown-rump length in chromosomally normal fetuses.
  • Trisomy 21 fetuses exhibited a significantly reduced median ear length compared to normal fetuses (0.45 mm reduction).
  • However, only 6.3% of trisomy 21 cases fell below the 5th centile of normal ear length.

Conclusions:

  • While fetal ear length is reduced in trisomy 21 fetuses at 11-14 weeks gestation, the deviation is minimal.
  • Fetal ear length measurement alone is not sufficiently sensitive or specific for effective screening of trisomy 21.
Abstract

Related Concept Videos

Meiosis I03:20

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...